Inicio › Colitis ulcerativa › California
Ensayos clínicos de Colitis ulcerativa en California
41 estudios sobre Colitis ulcerativa buscan participantes en California.
Ciudades en California
- San Diego16 estudios
- Los Angeles13 estudios
- Mountain View8 estudios
- Lancaster8 estudios
- Anaheim7 estudios
- Westminster5 estudios
- San Francisco4 estudios
- Victorville4 estudios
- San Bernardino3 estudios
- Orange3 estudios
- Oxnard3 estudios
- Newport Beach3 estudios
- Chula Vista3 estudios
- Murrieta3 estudios
- Thousand Oaks3 estudios
- Garden Grove3 estudios
- Folsom3 estudios
- Sacramento3 estudios
Texto oficial del estudio (inglés)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-018, San Diego
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07845487Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- y 2 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 024, Canoga Park
- Site 023, La Jolla
- Site 012, Lancaster
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Palo Alto
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT06619990A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Gastro Care Institute, Lancaster
- Medical Associates Research Group, Inc., San Diego
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06979336A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Clinnova Research ( Site 1042), Anaheim
- Southern California Research Center ( Site 1044), Coronado
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research LLC, Lancaster
- y 7 más
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Loma Linda University Health System, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
- y 1 más
ReclutandoFase 2/3
Edades de 2 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- GMC Clinical Research, Folsom
- Om Research LLC, Temple City
- y 1 más
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinnova Research - Anaheim, Anaheim
- Om Research LLC, Lancaster
- Biopharma Informatic, LLC, Los Angeles
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Rady Children's Hospital /ID# 271873, San Diego
- University of California San Francisco - Mission Bay /ID# 273022, San Francisco
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07071519A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- United Medical Doctors CA - Site Number: 8400044, Murrieta
- Om Research, LLC - Victorville - Site Number: 8400022, Victorville
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07185009A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT06581328A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
- Alliance Research Institute - Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- y 13 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Chula Vista
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 18 ago 2026 · NCT07686081Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
- Cedars Sinai Medical Center, Los Angeles
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT07034443Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- y 1 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Gastroenterology Medical Clinic (Objective Health), Folsom
- Center for Colorectal Innovation, Los Angeles
- Hoag Hospital, Newport Beach
- y 1 más
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06100289A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
- Southern California GI and Liver Centers (SCLC), Coronado
- Valley View Research, Garden Grove
- y 6 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT06598943An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Scripps Clinic Torrey Pines, La Jolla
- United Medical Doctors, Los Alamitos
- United Medical Doctors, Los Alamitos
ReclutandoEstudio observacional
Edades de 18 a 64 · Todos los sexos · Actualizado el 9 jul 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Valley View Wellness Medical Center, Garden Grove
- Loma Linda Children's Hospital, Loma Linda
- Loma Linda University Clinical Trial Center, Loma Linda
- y 7 más
ReclutandoFase 2
Edades de 12 a 17 · Todos los sexos · Actualizado el 8 jul 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Amicis Research Center, Valencia
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 12 jun 2026 · NCT05666960The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
- Children's Hospital Los Angeles, Los Angeles
ReclutandoFase 2
Edades de 7 a 21 · Todos los sexos · Actualizado el 4 jun 2026 · NCT05218850A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
ReclutandoFase 3
Edades de 2 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400009, Escondido
- Investigational Site Number: 8400006, Lancaster
- Investigational Site Number: 8400025, Thousand Oaks
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 23 abr 2026 · NCT06975722Fermented Food-Supplemented Diet in Ulcerative Colitis
- Stanford University, Palo Alto
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT04401605The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
- Stanford University, Palo Alto
Reclutando
Edades de 18 a 70 · Todos los sexos · Actualizado el 27 feb 2026 · NCT03615690Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 27 feb 2026 · NCT06495658Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Los Angeles Health, Los Angeles
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 8 ene 2026 · NCT05987852Effects of Pomegranate Juice on Ulcerative Colitis
- West Los Angeles VA Medical Center, Los Angeles
- UCLA Center for Human Nutrition, Los Angeles
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 dic 2025 · NCT07115862Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 008, Garden Grove
ReclutandoFase 4
Edades de 5 a 17 · Todos los sexos · Actualizado el 16 sept 2025 · NCT04314375Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
- University of California San Diego, San Diego
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 mar 2024 · NCT06311123De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.